Global Generics Focus Stragen specializes in Selected and Advanced Generics and Consumer Health products with a global footprint across 60 markets, presenting multiple cross-sell opportunities for regional distributors, contract manufacturing, and licensing collaborations.

European Manufacturing All final products are 100% manufactured in Europe, aligning with quality standards and potential customers prioritizing EU-sourced APIs and GMP-compliant supply chains, enabling trust-based sales pitches to European hospital networks and pharmacies.

Consumer Health Expansion Beyond generics, Stragen is diversifying into Consumer Health products and early-stage development of patented drugs, offering a pipeline for strategic partnerships, co-development deals, and private-label opportunities with retailers and health platforms.

Strategic Partnerships With a network of 10 dedicated affiliates and a history of exclusive launches (e.g., SniZtop Gum in Switzerland), there is a clear avenue for regional alliances, distribution agreements, and co-marketing initiatives to accelerate market access.

Growth & Financing Signals Revenue range ($10M–$25M) combined with a lean mid-market employee base suggests pricing opportunities, service level agreements, and scalable manufacturing or API supply arrangements to support larger buyers seeking reliable EU-manufactured generics and consumer health products.